Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Back to Industry News
Medtech

UltraGreen.ai Starts Gauging Interest for Singapore IPO, Bloomberg Reports

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Bloomberg.com
medtech related image for: UltraGreen.ai Starts Gauging Interest for Singapore IPO, Bloomberg Reports

Photo by Ozkan Guner on Unsplash

TL;DR

Singapore's UltraGreen.ai, a fluorescence technology company, is considering an IPO in Singapore and has begun investor education meetings. Sources indicate the company aims to raise roughly $400 million through the listing, which could happen as early as December. UltraGreen.ai, a Singapore-based company specializing in fluorescence technology for surgical imaging, is exploring a potential initial public offering (IPO) in Singapore, according to Bloomberg.com. The company has commenced investor education meetings, signaling its intent to gauge investor interest. Sources familiar with the matter suggest UltraGreen.ai aims to raise approximately $400 million.

Key takeaways

  • ai, a Singapore-based company specializing in fluorescence technology for surgical imaging, is exploring a potential initial public offering (IPO) in Singapore, according to Bloomberg
  • The company has commenced investor education meetings, signaling its intent to gauge investor interest
  • Sources familiar with the matter suggest UltraGreen
UltraGreen.ai, a Singapore-based company specializing in fluorescence technology for surgical imaging, is exploring a potential initial public offering (IPO) in Singapore, according to Bloomberg.com. The company has commenced investor education meetings, signaling its intent to gauge investor interest. Sources familiar with the matter suggest UltraGreen.ai aims to raise approximately $400 million through the listing, potentially occurring as early as December. This move could represent a significant expansion of capital market activity within Singapore's medtech sector. Further details regarding the company's valuation and the intended use of funds from the IPO are currently unavailable.

Related Topics

UltraGreen.aiIPOSingaporesurgical imagingfluorescence technologymedtechinitial public offering

Verified mention available

Free to claim

Is this your company?

Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.

Set up alerts Takes under 1 minute • Verified manually

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original